Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001455859-10-000003
Filing Date
2010-02-23
Accepted
2010-02-23 11:49:09
Documents
1
Period of Report
2010-02-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3814
  Complete submission text file 0001455859-10-000003.txt   5849
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS BIOTECHNOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address IMCLONE SYSTEMS INCORPORATED 180 VARICK STREET, 6TH FLOOR NEW YORK NY 10014
Business Address
Stancic Ana (Reporting) CIK: 0001320271 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17263 | Film No.: 10624883